• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS MEDICAL SYSTEMS HEART START XL; DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS MEDICAL SYSTEMS HEART START XL; DEFIBRILLATOR Back to Search Results
Model Number M4735A
Device Problems Failure to Analyze Signal (1539); Defibrillation/Stimulation Problem (1573)
Patient Problem Atrial Fibrillation (1729)
Event Type  malfunction  
Event Description
It was reported to philips that the heartstart xl monitor / defibrillator did not provide synchronized cardioversion therapy to a patient experiencing atrial fibrillation.Patient outcome is unknown at this time.Further information has been requested.
 
Manufacturer Narrative
This complaint was updated from serious injury to non adverse event based on clinical review during investigation that there was no harm to the patient.Submission of a report does not constitute an admission that medical personnel, user facility, importer, distributor, manufacturer, or product caused or contributed to the event.
 
Event Description
It was reported to philips that the heartstart xl monitor / defibrillator did not provide synchronized cardioversion therapy to a patient experiencing atrial fibrillation.This complaint was updated from serious injury to non adverse event based on clinical review during investigation that there was no harm to the patient.On (b)(6) 2019 this heartstart xl defibrillator was used for synchronized cardioversion via defib pads on a patient with atrial fibrillation and a heartrate of 140 beats per minute (bpm).The brand of defib pads was not reported.The users attempted 2 shocks at 100j and reported that "no shock was triggered after charging the device".A third attempt at 100j had the same result.The users checked the electrodes, powered the device off then on, and tried a 4th time to deliver 100j but with the same result.They then switched to a different defibrillator to treat the patient.No ecg strips or case events files were submitted to philips for evaluation.The customer¿s biomedical engineer removed and tested the device, including an ecg test, and found it to be fully functional.The device was evaluated at the philips bench.The reported problem could not be replicated.The device passed all performance tests.Philips is unable to determine the cause of the reported symptom as the symptom could not be reproduced and the device passed all testing.Ecg strips from the event were not provided and could not be part of the analysis.The device was returned to the customer from the philips bench.The device remains in use at the customer site.The information gathered for this report does not provide evidence of a systemic, design, or labeling problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEART START XL
Type of Device
DEFIBRILLATOR
Manufacturer (Section D)
PHILIPS MEDICAL SYSTEMS
3000 minuteman road
andover MA 01810
MDR Report Key9501447
MDR Text Key172212039
Report Number1218950-2019-09610
Device Sequence Number1
Product Code MKJ
Combination Product (y/n)N
PMA/PMN Number
K001725
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 12/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM4735A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/06/2020
Was the Report Sent to FDA? No
Date Manufacturer Received12/13/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age50 YR
-
-